Boomerang Medical

Boomerang Medical Women-led, clinical-stage co. developing technology to advance the treatment of autoimmune diseases.

🎉Another patient said yes to the BOOM-IBD2 clinical trial at Columbia University. We are beyond grateful for the care th...
08/21/2026

🎉Another patient said yes to the BOOM-IBD2 clinical trial at Columbia University. We are beyond grateful for the care they bring to every person they enroll!

BOOM-IBD2 is the first-ever pivotal trial of a neuromodulation device in inflammatory bowel disease. Ulcerative colitis affects millions of people and profoundly impacts their daily lives.

A HUGE thank you to the patient who took this step! Want to learn more about the trial?

Link in comments.



Columbia Surgery

Thank you Frank, Columbia Surgery, Dr. Marco Zoccali and staff! We couldn’t do this without you!
08/13/2026

Thank you Frank, Columbia Surgery, Dr. Marco Zoccali and staff! We couldn’t do this without you!

🎉And… another patient said yes to the BOOM-IBD2 clinical trial. Thank you to Kansas Gastroenterology and Wichita Urology...
08/13/2026

🎉And… another patient said yes to the BOOM-IBD2 clinical trial. Thank you to Kansas Gastroenterology and Wichita Urology for the care you bring to every single person you enroll.

BOOM-IBD2 is the first-ever pivotal trial of a neuromodulation device in inflammatory bowel disease. Ulcerative colitis affects millions of people and profoundly impacts their daily lives.

And a HUGE thank you to the patient who took this step! Want to learn more about the trial?

Link in comments.



Kansas Gastroenterology,
Wichita Urology

Another two patients said yes to the BOOM-IBD2 clinical trial! We are grateful to the Center for Colorectal Innovation t...
08/10/2026

Another two patients said yes to the BOOM-IBD2 clinical trial! We are grateful to the Center for Colorectal Innovation team and the care they put into every person they enroll. And, a huge thank you to the patients who took this step!

BOOM-IBD2 is the first-ever pivotal trial of a neuromodulation device in inflammatory bowel disease. Ulcerative colitis affects millions of people and profoundly impacts their daily lives.

Want to learn more about the trial?

Link in comments.

We are grateful to the team at HOAG for enrolling another patient in the BOOM-IBD2 clinical trial and to the patient who...
08/07/2026

We are grateful to the team at HOAG for enrolling another patient in the BOOM-IBD2 clinical trial and to the patient who took this step. The care HOAG puts into every patient truly makes a difference.

BOOM-IBD2 is the first-ever pivotal trial of a neuromodulation device in inflammatory bowel disease. Ulcerative colitis affects millions of people and profoundly impacts their daily lives.

Want to learn more about the trial?

Link in comments.

Two more patients said yes to the BOOM-IBD2 clinical trial! We’re thankful for the Objective Health St. Louis team and t...
07/22/2026

Two more patients said yes to the BOOM-IBD2 clinical trial! We’re thankful for the Objective Health St. Louis team and the care they pour into every single person they enroll. And thank you to the patients who took this step.

BOOM-IBD2 is the first-ever pivotal trial of a neuromodulation device in inflammatory bowel disease. Ulcerative colitis affects millions of
people and profoundly impacts their daily lives.


🎉BIG NEWS: We just enrolled our 50th patient in the BOOM-IBD2 pivotal trial for ulcerative colitis!This milestone wouldn...
07/17/2026

🎉BIG NEWS: We just enrolled our 50th patient in the BOOM-IBD2 pivotal trial for ulcerative colitis!

This milestone wouldn’t have been possible without our amazing clinical partner sites, investigators, and coordinators; or the patients brave enough to say yes.

Thank you all for your dedication to advancing care for people living with ulcerative colitis.

Here’s to the next 50! 💪

Two more patients said yes to the BOOM-IBD2 clinical trial. Thank you to Kansas Gastroenterology for the care they bring...
07/16/2026

Two more patients said yes to the BOOM-IBD2 clinical trial. Thank you to Kansas Gastroenterology for the care they bring to every single person they enroll.

BOOM-IBD2 is the first-ever pivotal trial of a neuromodulation device in inflammatory bowel disease. Ulcerative colitis affects millions of people and profoundly impacts their daily lives.

And thank you to the patient who took this step. Want to learn more about the trial?

Another patient just said yes to the BOOM-IBD2 clinical trial. Thank you to the Center for Colorectal Innovation for the...
06/24/2026

Another patient just said yes to the BOOM-IBD2 clinical trial. Thank you to the Center for Colorectal Innovation for the care they bring to every single person they enroll.

BOOM-IBD2 is the first-ever pivotal trial of a neuromodulation device in inflammatory bowel disease. Ulcerative colitis affects millions of people and profoundly impacts their daily lives.
And thank you to the patient who took this step. Want to learn more about the trial?

Link in comments.

A huge thank you to the research team at GI Alliance in Flowood, Mississippi for enrolling two patients in the BOOM-IBD2...
06/19/2026

A huge thank you to the research team at GI Alliance in Flowood, Mississippi for enrolling two patients in the BOOM-IBD2 Clinical Trial. And, for the care they bring to every patient they enroll. And, thank you to the patients who said yes. BOOM-IBD2 is the first-ever pivotal trial of a neuromodulation device in inflammatory bowel disease. Ulcerative colitis affects millions of people and profoundly impacts theirdaily lives.
Living with UC and want to learn more? Link in the comments.

Address

2495 Hospital Drive, Suite 300, Mountain View, CA 94040
Mountain View, CA
94040

Website

,

Alerts

Be the first to know and let us send you an email when Boomerang Medical posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share

Category